Stratview Research has published a new report titled “Chemiluminescence Immunoassay (CLIA) Analyzers Market” which is segmented By Type (High Throughput, Medium Throughput, Low Throughput), Product (Reagents, Consumables, Analyzers), Application (Oncology & Endocrinology, Hepatitis, and Retroviruses, Cardiac Markers, Bone and Mineral Disorders, Auto-Immune Diseases, Others), End-User (Hospitals & Clinics, Pharmaceutical Companies, Medical & Diagnostic Laboratories s) and Region.
As per the study, the Chemiluminescence Immunoassay (CLIA) Analyzers Market is expected to grow from USD 5.2 billion in 2020 to USD 7.2 billion by 2026 at a CAGR of over 5.8% during the forecast period.
Report Highlights
This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.
The market is bifurcated into various segments. Below given is the segment-wise analysis -
Based on end-user, the market has been segmented into hospitals & clinics, pharmaceutical companies, and medical & diagnostic laboratories. The hospitals & clinics segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled staff.
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced chemiluminescence immunoassay analyzers and the presence of key market players such as Abbott Laboratories (US) and Johnson & Johnson (US). The market in Asia-Pacific is expected to be driven by the rising number of people suffering from chronic diseases.
Who are the Key Players in the Market?
This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Chemiluminescence Immunoassay (CLIA) Analyzers Market:
· Siemens AG (Germany)
· bioMérieux SA (France)
· Abbott Laboratories (US)
· Johnson & Johnson (US)
· Tosoh Corporation (Japan)
· Randox Laboratories (UK)
· Ortho Clinical Diagnostics (US)
· Sysmex Corporation (Japan)
· DiaSorin (Italy)
· Beckman Coulter Inc. (US)
· Danaher Corporation (US)
· F. Hoffmann-La Roche AG (Switzerland)
· Shenzhen New Industries Biomedical Engineering Co. Ltd (China)
Key questions answered by the report
- What is the projected CAGR for revenue from the Chemiluminescence Immunoassay (CLIA) Analyzers Market during the forecast period?
- What would be the market be valued at by 2026?
- What is a major driving factor for growth of the market?
- Which region accounted for largest revenue share in the Chemiluminescence Immunoassay (CLIA) Analyzers Market?
- Which are the major market players?
Request a sample here- https://www.stratviewresearch.com/Request-Sample/2405/Chemiluminescence-Immunoassay-(CLIA)-Analyzers-Market.html#form
Custom Research:
Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to sales@stratviewresearch.com. Or connect with our experts at +1-313-307-4176.
About Us
Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.
Write a comment